Synthesis and applications of [60]fullerene nanoconjugate with 5-aminolevulinic acid and its glycoconjugate as drug delivery vehicles
Maciej SerdaInstitute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, PolandRobert GaweckiA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandMateusz DulskiInstitute of Materials Science, University of Silesia in Katowice, 75 Pulku Piechoty, 1A, Chorzow, 41-500, PolandMieczysław SajewiczInstitute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, PolandE. TalikA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandM. SzubkaA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandMaciej ZubkoDepartment of Physics, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Králové, Czech RepublicKatarzyna MalarzA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandAnna Mrozek‐WilczkiewiczA. Chełkowski Institute of Physics, University of Silesia, 75 Pulku Piechoty 1, 41-500 Chorzow, PolandRobert MusiołInstitute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, Poland
2022en
ABI
Abstract
The 5-aminolevulinic acid (5-ALA) prodrug is widely used in clinical applications, primarily for skin cancer treatments and to visualize brain tumors in neurosurgery.
Identifiers
Citations and references
Cited by 20 references